Minakem Generic APIs Minakem Generic APIs

X

CAS 1246815-34-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 1246815-34-8
Also known as: 1246815-34-8, 3-[4-(trideuteriomethyl)imidazol-1-yl]-5-(trifluoromethyl)aniline
Molecular Formula
C11H10F3N3
Molecular Weight
244.23  g/mol
InChI Key
WWTGXYAJVXKEKL-FIBGUPNXSA-N

1 2D Structure

CAS 1246815-34-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[4-(trideuteriomethyl)imidazol-1-yl]-5-(trifluoromethyl)aniline
2.1.2 InChI
InChI=1S/C11H10F3N3/c1-7-5-17(6-16-7)10-3-8(11(12,13)14)2-9(15)4-10/h2-6H,15H2,1H3/i1D3
2.1.3 InChI Key
WWTGXYAJVXKEKL-FIBGUPNXSA-N
2.1.4 Canonical SMILES
CC1=CN(C=N1)C2=CC(=CC(=C2)N)C(F)(F)F
2.1.5 Isomeric SMILES
[2H]C([2H])([2H])C1=CN(C=N1)C2=CC(=CC(=C2)N)C(F)(F)F
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 1246815-34-8

2. 3-[4-(trideuteriomethyl)imidazol-1-yl]-5-(trifluoromethyl)aniline

2.3 Create Date
2013-11-01
3 Chemical and Physical Properties
Molecular Weight 244.23 g/mol
Molecular Formula C11H10F3N3
XLogP32.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count1
Exact Mass244.10151206 g/mol
Monoisotopic Mass244.10151206 g/mol
Topological Polar Surface Area43.8 Ų
Heavy Atom Count17
Formal Charge0
Complexity269
Isotope Atom Count3
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
350-03-8
Nilotinib
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and interme...
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.
Aptra Synthesis

CRS 2024

Not Confirmed

envelop Contact Supplier
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY